#6 - DocuSign (NASDAQ:DOCU)
DocuSign (NASDAQ:DOCU) was a pandemic winner and then a victim of panic selling. But this is an example of where the buyers had it right, and the sellers may be missing the longer-term story.
For the uninitiated, DocuSign is on a paperless society's vanguard by enabling electronic signatures for important financial documents. For obvious reasons, the company enjoyed tremendous growth during the pandemic as contactless everything was
However, DocuSign’s service was an idea whose time had come long before the novel coronavirus made it necessary. And the simple fact is that once consumers have begun signing documents remotely, they’re not going back. Don’t believe me? Let me ask you when the last time your child has called you out of anything other than necessity is? I’ll hang up and wait. There are certain times when we hit an inflection point and aren’t going back.
Those investors who bought DOCU stock on the dip in September have been rewarded with a tidy gain of around 15%. And analysts believe the stock has further to go.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More - Current Price
- $94.41
- Consensus Rating
- Hold
- Ratings Breakdown
- 3 Buy Ratings, 7 Hold Ratings, 3 Sell Ratings.
- Consensus Price Target
- $92.45 (2.1% Downside)
